Digitalni repozitorij raziskovalnih organizacij Slovenije

Izpis gradiva
A+ | A- | Pomoč | SLO | ENG

Naslov:From crisis to routine – standardization of SARS-CoV-2 genome detection by enhanced EQA schemes in a scientific pandemic network
Avtorji:ID Kammel, Martin (Avtor)
ID Grunert, Hans-Peter (Avtor)
ID Zimmermann, Anika (Avtor)
ID Martin, Annemarie (Avtor)
ID Lindig, Vanessa (Avtor)
ID Milavec, Mojca (Avtor)
Datoteke:URL URL - Izvorni URL, za dostop obiščite https://doi.org/10.1016/j.ijmm.2025.151656
 
.pdf PDF - Predstavitvena datoteka, prenos (10,30 MB)
MD5: 35244153C26B6E70E6037E6D16E6DEE7
 
.zip ZIP - Priloga, prenos (733,09 KB)
MD5: B3E3EBDE61ED2AEBBDACA7AC724633B4
Opis: Dopolnilne informacije
 
Jezik:Angleški jezik
Tipologija:1.01 - Izvirni znanstveni članek
Organizacija:Logo NIB - Nacionalni inštitut za biologijo
Povzetek:In the beginning of 2020, the outbreak of the COVID-19 pandemic led to a crisis in which diagnostic methods for the genome detection of SARS-CoV-2 were urgently needed. Based on the very early publication of the basic principles for a diagnostic test for the genome detection of SARS-CoV-2, the first noncommercial laboratory-developed tests (LDTs) and commercial tests were introduced. As there was considerable uncertainty about the reliability and performance of different tests and different laboratories, INSTAND established external quality assessment (EQA) schemes for the detection of SARS-CoV-2 starting in April 2020. In close partnership in a scientific network, the EQA schemes were enhanced, especially the April, June and November 2020 terms. The enhancement included: (i) immediate provision of suitable virus including variants of concern at the beginning of the pandemic outbreak, (ii) short frequency of EQA schemes, (iii) concentration dependency of the testing and sensitivity check, achieved by using SARS-CoV-2-positive samples from a 10-fold dilution series of the same starting material, (iv) specificity check of the testing, achieved by using SARS-CoV-2-negative samples containing human coronaviruses or MERS CoV, (v) revealed samples for orientation on test performance during an ongoing or at the start of an EQA scheme using a pre-quantified SARS-CoV-2-positive EQA sample with a low viral RNA load of only 1 570 copies/mL assigned by digital PCR (dPCR) in June 2020 and (vi) quantified reference materials based on the experiences of the first two EQA schemes with dPCR-assigned values in copies/mL beginning in November 2020 for self-evaluation of the applied test system. This manuscript summarizes the results of a total of 13 EQA schemes for the detection of SARS-CoV-2 between April 2020 and June 2023 in which a total of 1 413 laboratories from 49 countries participated. The qualitative results for the detection of SARS-CoV-2-positive samples were between 95.8 % and 99.7 % correct positive, excluding extremely low concentration samples. For all SARS-CoV-2-negative EQA samples, the qualitative success rates ranged from 95.1 % to 99.4 % correct negative results. The widely varying values for the cycle threshold (Ct)/crossing point (Cq) reported for the different target genes and test systems were striking. A few laboratories reported quantitative results in copies/mL for several VOCs with an acceptable rate of over 93 % correct positive results in the majority of cases. The description of the enhanced EQA schemes for SARS-CoV-2 detection in terms of timing and scope can serve as a blueprint for the rapid development of a quality assessment of diagnostics for an emerging pathogen.
Ključne besede:COVID-19 pandemic, SARS-CoV-2, virus genome detection tests, reference materials, external quality assessment, laboratory medicine, epidemiology
Status publikacije:Objavljeno
Verzija publikacije:Objavljena publikacija
Datum objave:01.06.2025
Leto izida:2025
Št. strani:str. 1-24
Številčenje:Vol. 319, [art. no.] ǂ151656
PID:20.500.12556/DiRROS-22722 Novo okno
UDK:578
ISSN pri članku:1438-4221
DOI:10.1016/j.ijmm.2025.151656 Novo okno
COBISS.SI-ID:239799299 Novo okno
Opomba:Soavtorica iz Slovenije: Mojca Milavec;
Datum objave v DiRROS:18.06.2025
Število ogledov:510
Število prenosov:455
Metapodatki:XML DC-XML DC-RDF
:
Kopiraj citat
  
Objavi na:Bookmark and Share


Postavite miškin kazalec na naslov za izpis povzetka. Klik na naslov izpiše podrobnosti ali sproži prenos.

Gradivo je del revije

Naslov:International journal of medical microbiology
Skrajšan naslov:Int J Med Microbiol
Založnik:Urban & Fischer
ISSN:1438-4221
COBISS.SI-ID:2144788 Novo okno

Gradivo je financirano iz projekta

Financer:German Federal Ministry of Health

Licence

Licenca:CC BY-NC-ND 4.0, Creative Commons Priznanje avtorstva-Nekomercialno-Brez predelav 4.0 Mednarodna
Povezava:http://creativecommons.org/licenses/by-nc-nd/4.0/deed.sl
Opis:Najbolj omejujoča licenca Creative Commons. Uporabniki lahko prenesejo in delijo delo v nekomercialne namene in ga ne smejo uporabiti za nobene druge namene.

Sekundarni jezik

Jezik:Slovenski jezik
Naslov:From crisis to routine
Ključne besede:pandemija COVID-19, SARS-CoV-2, testi za odkrivanje genoma virusa, referenčni materiali, zunanja ocena kakovosti, laboratorijska medicina, epidemiologija


Nazaj